UPDATE on OSTEOPOROSIS

New Developments That are Changing Patient Care

Best prevention: Densitometry, drugs, determination

Editor-in-Chief, OBG Management
Chief, Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, Boston
Kate Macy Ladd Professor of Obstetrics, Gynecology, and Reproductive Biology,
Harvard Medical School,  Boston

Ob/Gyns are well trained to care for more than 99% of women with osteopenia and osteoporosis. Yet most women at risk are not being diagnosed or treated. Since recent publication of randomized clinical trials, however, we have clearer direction on the decisive diagnosis and management questions.